Featured,Shroom News Psygen Granted License to Become First Dedicated Psychedelics Manufacturing Facility in Canada By Dennis Mutua January 21, 2022 Manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications Psygen Labs announced having been granted a dealer’s license by Heath Canada to become Canada’s first dedicated ...
Featured,Trends & Articles Filament Health and Cybin Therapeutics Enters Into a Licensing Agreement By Dennis Mutua January 18, 2022 Clinical-stage natural psychedelic drug development company supporting treatment of mental health conditions Filament Health Corp. (NEO: FH) (OTCQB: FHLLF) announced having entered into a licensing agreement with Cybin Therapeutic...
Featured,Trends & Articles FDA Grants Wesana Health Pre-IND Meeting For SANA-013 By Dennis Mutua January 12, 2022 Emerging life sciences company specializing in development and delivery of psychedelic and naturally extracted therapies to treat traumatic brain injuries Wesana Health Holdings Inc. (CSE: WESA) (OTCQB: WSNAF) announced having bee...
Featured,Shroom News Stephen Hurst Steps Down From MindMed’s Board of Directors By Dennis Mutua January 10, 2022 Biotechnology company developing and deploying psychedelic inspired medicines to treat addiction and mental conditions MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced Stephen Hurst has resigned from his position as a director to...
Featured,Trends & Articles Washington City Approves Measure to Decriminalize Psychedelics Substances By Dennis Mutua January 03, 2022 The city of Port Townsend becomes the latest entry in the list of United States cities to decriminalize possession and use of natural psychedelics also known as entheogenic fungi and plants. The city approved this measure last wee...
Featured,Trends & Articles Colorado Activists Files Petition to Legalize Psychedelics Substances By Dennis Mutua December 29, 2021 A group of activists from Colorado have filed a petition seeking to have growth and possession psychedelics substances across the state legalized come next year. The activist group is also advocating for establishment of a system ...
Featured,Spotlight Stock Tryp Therapeutics Receives FDA Approval for its Study Using Psilocybin to Treat Binge Eating Disorder By Dennis Mutua December 24, 2021 Pharmaceutical company focusing on developing psilocybin-based compounds for the treatment of orphan diseases and other diseases with high unmet medical needs Tryp Therapeutics Inc. (CNSX: TRYP) announced having been granted appro...
Featured,Trends & Articles Washington City Votes in Favor of Decriminalizing Psychedelics By Dennis Mutua December 23, 2021 Earlier in the week, the city council of Port Townsend, Washington voted in favor of decriminalizing fungi and entheogenic plants across the city. This move makes the city to join an expanding list of cities and states across the ...